{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T06:42:05Z","timestamp":1740120125875,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s12185-024-03712-4","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:03:03Z","timestamp":1707487383000},"page":"407-415","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Age-related variation in coagulation factors in non-valvular atrial fibrillation patients receiving direct oral anticoagulants"],"prefix":"10.1007","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6650-0567","authenticated-orcid":false,"given":"Osamu","family":"Kumano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4769-5925","authenticated-orcid":false,"given":"Shinya","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4989-7974","authenticated-orcid":false,"given":"Masako","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5287-8259","authenticated-orcid":false,"given":"Yoshimori","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Yasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1854-4543","authenticated-orcid":false,"given":"Masahiro","family":"Ieko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"For the Japanese Study Group for the Assessment of Direct Oral Anticoagulants","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumi","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Shiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitomi","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takako","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Akao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chika","family":"Kamata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Mitsuhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Tomoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuuta","family":"Tomoyose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Nishiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihoko","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumasa","family":"Ohmura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumiyoshi","family":"Naito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Shitamichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Juraku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Hatanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Kitano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenari","family":"Takaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,9]]},"reference":[{"key":"3712_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1177\/174182679400100211","volume":"1","author":"K Kario","year":"1994","unstructured":"Kario K, Matsuo T. High factor-VII activity in the elderly is related to vascular disease through activation of the coagulation system. J Cardiovasc Risk. 1994;1:165\u201371.","journal-title":"J Cardiovasc Risk"},{"key":"3712_CR2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/1047-2797(92)90100-5","volume":"2","author":"RP Tracy","year":"1992","unstructured":"Tracy RP, Bovill EG, Fried LP, Heiss G, Lee MH, Polak JF, et al. High factor-VII activity in the elderly is related to vascular disease through activation of the coagulation system. Ann Epidemiol. 1992;2:509\u201319.","journal-title":"Ann Epidemiol"},{"key":"3712_CR3","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/oxfordjournals.aje.a008799","volume":"143","author":"M Cushman","year":"1996","unstructured":"Cushman M, Yanez D, Psaty BM, Fried LP, Heiss G, Lee M, et al. Association of fibrinogen and coagulation factors VII and VIII with cardiovascular risk factors in the elderly: the Cardiovascular Health Study. Am J Epidemiol. 1996;143:665\u201376.","journal-title":"Am J Epidemiol"},{"key":"3712_CR4","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1182\/blood.V85.11.3144.bloodjournal85113144","volume":"85","author":"D Mari","year":"1995","unstructured":"Mari D, Mannucci PM, Coppola R, Bottasso B, Bauer KA, Rosenberg RD. Hypercoagulability in centenarians: the paradox of successful aging. Blood. 1995;85:3144\u20139.","journal-title":"Blood"},{"key":"3712_CR5","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, RE-LY Steering Committee and Investigators, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139\u201351.","journal-title":"N Engl J Med"},{"key":"3712_CR6","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, ARISTOTLE Committees and Investigators, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365:981\u201392.","journal-title":"N Engl J Med"},{"key":"3712_CR7","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","volume":"363","author":"R Bauersachs","year":"2010","unstructured":"Bauersachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H, Gallus AS, et al. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2010;363:2499\u2013510.","journal-title":"N Engl J Med"},{"key":"3712_CR8","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","volume":"369","author":"RP Giugliano","year":"2013","unstructured":"Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, ENGAGE AF-TIMI 48 Investigators, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369:2093\u2013104.","journal-title":"N Engl J Med"},{"key":"3712_CR9","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/jth.12149","volume":"11","author":"T Baglin","year":"2013","unstructured":"Baglin T, Hillarp A, Tripodi A, Elalamy I, Buller H, Ageno W. Measuring oral direct inhibitors of thrombin and factor Xa: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2013;11:756\u201360.","journal-title":"J Thromb Haemost"},{"issue":"Suppl 1","key":"3712_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/ijlh.12992","volume":"41","author":"RC Gosselin","year":"2019","unstructured":"Gosselin RC, Adcock DM, Douxfils J. An update on laboratory assessment for direct oral anticoagulants (DOACs). Int J Lab Hematol. 2019;41(Suppl 1):33\u20139.","journal-title":"Int J Lab Hematol"},{"key":"3712_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.thromres.2021.12.028","volume":"210","author":"O Kumano","year":"2022","unstructured":"Kumano O, Suzuki S, Yamazaki M, An Y, Yasaka M, Ieko M. Newly developed modified diluted prothrombin time reagent: a multi-centre validation in patients with non-valvular atrial fibrillation under direct oral anticoagulant therapy. Thromb Res. 2022;210:87\u201390.","journal-title":"Thromb Res"},{"key":"3712_CR12","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","volume":"285","author":"BF Gage","year":"2001","unstructured":"Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285:2864\u201370.","journal-title":"JAMA"},{"key":"3712_CR13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GYP Lip","year":"2010","unstructured":"Lip GYP, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137:263\u201372.","journal-title":"Chest"},{"key":"3712_CR14","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1378\/chest.10-0134","volume":"138","author":"R Pisters","year":"2010","unstructured":"Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJGM, Lip GYH. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010;138:1093\u2013100.","journal-title":"Chest"},{"key":"3712_CR15","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1007\/s12185-020-02983-x","volume":"112","author":"M Ieko","year":"2020","unstructured":"Ieko M, Komiyama Y, Yamazaki S, Katagiri H, Shimazu C, Naito S, Matsuda M, Yuki Y, Miyata K, Arai R, Kumano O, Emmi M, Yoshida T, Tanaka H, Okuhara T, Yamashita T, Sekine Y, Homma M, Kawai Y, Tohyama K. Int J Hematol. 2020;112:614\u201320.","journal-title":"Int J Hematol"},{"key":"3712_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1160\/TH12-04-0228","volume":"109","author":"H Mani","year":"2013","unstructured":"Mani H, Hesse C, Stratmann G, Lindhoff-Last E. Ex vivo effects of low-dose rivaroxaban on specific coagulation assays and coagulation factor activities in patients under real life conditions. Thromb Haemost. 2013;109:127\u201336.","journal-title":"Thromb Haemost"},{"key":"3712_CR17","unstructured":"Castellone DD, Castillo R, Depasse F, Doyle M, Halim AB, Kitchen S et al. Determination of coagulation factor activities using the one-stage clotting assay, in: Approved Guideline, 2nd edition, Clinical and Laboratory Standards Institute, Wayne, PA, 2016. CLSI Document H48-A."},{"key":"3712_CR18","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.thromres.2020.07.020","volume":"195","author":"M Ieko","year":"2020","unstructured":"Ieko M, Ohmura K, Naito S, Yoshida M, Sakuma I, Ikeda K, et al. Novel assay based on diluted prothrombin time reflects anticoagulant effects of direct oral factor Xa inhibitors: results of multicenter study in Japan. Thromb Res. 2020;195:158\u201364.","journal-title":"Thromb Res"},{"key":"3712_CR19","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/S0735-1097(98)00251-4","volume":"32","author":"K Kario","year":"1998","unstructured":"Kario K, Matsuo T, Kobayashi H, Kanai N, Hoshide S, Mitsuhashi T, et al. Endothelial cell damage and angiotensin-converting enzyme insertion\/deletion genotype in elderly hypertensive patients. J Am Coll Cardiol. 1998;32:444\u201350.","journal-title":"J Am Coll Cardiol"},{"key":"3712_CR20","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1056\/NEJMoa001066","volume":"349","author":"AA Ariyo","year":"2003","unstructured":"Ariyo AA, Tracy CTR. Lp(a) lipoprotein, vascular disease, and mortality in the elderly. N Engl J Med. 2003;349:2108\u201315.","journal-title":"N Engl J Med"},{"key":"3712_CR21","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/j.1538-7836.2008.02939.x","volume":"6","author":"PC Wong","year":"2008","unstructured":"Wong PC, Crain EJ, Xin B, Wexler RR, Lam PYS, Pinto DJ, et al. Apixaban, an oral, direct and highly selective factor Xa inhibitor: in vitro, antithrombotic and antihemostatic studies. J Thromb Haemost. 2008;6:820\u20139.","journal-title":"J Thromb Haemost"},{"key":"3712_CR22","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1111\/j.1538-7836.2008.03064.x","volume":"6","author":"T Furugohri","year":"2008","unstructured":"Furugohri T, Isobe K, Honda Y, Kamisato-Matsumoto C, Sugiyama N, Nagahara T, et al. DU-176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles. J Thromb Haemost. 2008;6:1542\u20139.","journal-title":"J Thromb Haemost"},{"key":"3712_CR23","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/j.1538-7836.2005.01166.x","volume":"3","author":"E Perzborn","year":"2005","unstructured":"Perzborn E, Strassburger J, Wilmen A, Pohlmann J, Roehrig S, Schlemmer K-H, et al. In vitro and in vivo studies of the novel antithrombotic agent BAY 59\u20137939\u2013an oral, direct Factor Xa inhibitor. J Thromb Haemost. 2005;3:514\u201321.","journal-title":"J Thromb Haemost"},{"key":"3712_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1752-0509-4-5","volume":"4","author":"AM Shibeko","year":"2010","unstructured":"Shibeko AM, Lobanova ES, Panteleev MA, Ataullakhanov FI. Blood flow controls coagulation onset via the positive feedback of factor VII activation by factor Xa. BMC Syst Biol. 2010;4:5.","journal-title":"BMC Syst Biol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-024-03712-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-024-03712-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-024-03712-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T13:14:32Z","timestamp":1711199672000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-024-03712-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,9]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["3712"],"URL":"https:\/\/doi.org\/10.1007\/s12185-024-03712-4","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"type":"print","value":"0925-5710"},{"type":"electronic","value":"1865-3774"}],"subject":[],"published":{"date-parts":[[2024,2,9]]},"assertion":[{"value":"22 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"O. Kumano was an employee of Sysmex Corporation at the time the work was carried out.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}